MEDTRONIC HEART VALVES DIVISION EVOLUT FX DCS; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV
|
Back to Search Results |
|
Model Number D-EVOLUTFX-34 |
Device Problem
Device Dislodged or Dislocated (2923)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 04/10/2024 |
Event Type
malfunction
|
Manufacturer Narrative
|
Updated data: evolutfx-34 (serial: (b)(6) added as concomitant device.Added codes: g07001 b18 continuation of d10: product id l-evolutfx-34 (lot: unknown); product type: 0195-heart valves section d references the main component of the system.Other medical products in use during the event include: brand name evolut fx; product id (b)(4) (serial: (b)(6), product type: 0195-heart valves medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
Additional information was received that the deployment starting point was at the bottom of the pigtail catheter.Prior to the valve dislodging, the implant depth was 3 millimeter (mm) on the non-coronary cusp (ncc) and 4 mm on the left coronary cusp (lcc).The valve dislodged ventricular to a depth of 10 mm.
|
|
Manufacturer Narrative
|
Updated b.5 medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Manufacturer Narrative
|
Continuation of d10: product id evolutfx-34 (serial: (b)(4) ); product type: 0195-heart valves.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
Medtronic received information that during implant of this transcatheter bioprosthetic valve, a perimeter of 29 was measured in transesophageal echocardiogram (tee) with no corresponding computed tomography (ct) measurement.There was abundant calcium in the aortic valve (av), therefore a pre-implant balloon aortic valvuloplasty (bav) was performed.While attempting to position the valve, there was no anchoring of the prosthesis.At minimal pressure, the valve dislodged into the left ventricular outflow tract (lvot).For patient safety, the team decided not to release the valve.The valve was recaptured, removed from the patient and discarded.The patient was transferred without prosthetic replacement.No adverse patient effects were reported.
|
|
Search Alerts/Recalls
|
|
|